Financhill
Sell
25

OCSL Quote, Financials, Valuation and Earnings

Last price:
$13.58
Seasonality move :
-0.76%
Day range:
$13.56 - $13.76
52-week range:
$12.44 - $16.50
Dividend yield:
12.89%
P/E ratio:
35.69x
P/S ratio:
3.90x
P/B ratio:
0.82x
Volume:
801.2K
Avg. volume:
660.4K
1-year change:
-17.04%
Market cap:
$1.2B
Revenue:
$299.7M
EPS (TTM):
$0.38

Analysts' Opinion

  • Consensus Rating
    Oaktree Specialty Lending Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $13.70, Oaktree Specialty Lending Corp. has an estimated upside of 0.88% from its current price of $13.58.
  • Price Target Downside
    According to analysts, the lowest downside price target is $13.00 representing 100% downside risk from its current price of $13.58.

Fair Value

  • According to the consensus of 6 analysts, Oaktree Specialty Lending Corp. has 0.88% upside to fair value with a price target of $13.70 per share.

OCSL vs. S&P 500

  • Over the past 5 trading days, Oaktree Specialty Lending Corp. has underperformed the S&P 500 by -1.21% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Oaktree Specialty Lending Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Oaktree Specialty Lending Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Oaktree Specialty Lending Corp. reported revenues of $84.3M.

Earnings Growth

  • Oaktree Specialty Lending Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Oaktree Specialty Lending Corp. reported earnings per share of $0.28.
Enterprise value:
2.6B
EV / Invested capital:
0.88x
Price / LTM sales:
3.90x
EV / EBIT:
17.24x
EV / Revenue:
8.69x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
18.28x
Price / Operating cash flow:
8.21x
Enterprise value / EBITDA:
17.24x
Gross Profit (TTM):
$261.4M
Return On Assets:
1.11%
Net Income Margin (TTM):
11.32%
Return On Equity:
2.31%
Return On Invested Capital:
1.13%
Operating Margin:
60.38%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $346.1M $245.3M $299.7M $42.8M $84.3M
Gross Profit $269.7M $175.3M $261.4M $26.9M $71.1M
Operating Income $230.7M $186.4M $151M $68.3M $50.9M
EBITDA $230.7M $186.4M $151M $68.3M $50.9M
Diluted EPS $1.58 $0.71 $0.38 $0.45 $0.28
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $65.5M $134.7M $306.1M $164.5M $135.2M
Total Assets $2.6B $2.6B $3.2B $3.2B $3B
Current Liabilities $82.9M $117.1M $169.2M $459.7M $139.5M
Total Liabilities $1.3B $1.4B $1.7B $1.7B $1.5B
Total Equity $1.3B $1.2B $1.5B $1.5B $1.5B
Total Debt $1.3B $1.3B $1.6B $1.6B $1.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $58.9M $214.3M $142.4M -$11.2M $47.8M
Cash From Investing $169.8M -$195.2M $86M $106.7M -$46.5M
Cash From Financing -$110.4M -$86.8M -$229.3M -$125.2M -$234K
Free Cash Flow $58.9M $214.3M $142.4M -$11.2M $47.8M
OCSL
Sector
Market Cap
$1.2B
$555.2M
Price % of 52-Week High
82.3%
90.06%
Dividend Yield
12.89%
1.64%
Shareholder Yield
9.73%
3.16%
1-Year Price Total Return
-17.04%
1.45%
Beta (5-Year)
0.507
0.481
Dividend yield:
12.89%
Annualized payout:
$1.84
Payout ratio:
143.37%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $13.67
200-day SMA
Sell
Level $14.09
Bollinger Bands (100)
Sell
Level 13.14 - 14.04
Chaikin Money Flow
Sell
Level -2.6M
20-day SMA
Buy
Level $13.57
Relative Strength Index (RSI14)
Sell
Level 49.80
ADX Line
Sell
Level 12.35
Williams %R
Neutral
Level -39.7059
50-day SMA
Buy
Level $13.43
MACD (12, 26)
Buy
Level 0.03
25-day Aroon Oscillator
Sell
Level -52
On Balance Volume
Sell
Level -15.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.3001)
Sell
CA Score (Annual)
Level (-0.3172)
Buy
Beneish M-Score (Annual)
Level (-3.4141)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.6618)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Oaktree Specialty Lending Corp., is a closed-end investment fund, which engages in the provision of credit solutions to companies with limited access to public or syndicated capital markets. Its objective is to generate current income and capital appreciation by providing companies with solutions including first and second lien loans, unsecured and mezzanine loans, and preferred equity. The company was founded on February 15, 2007 and is headquartered in Los Angeles, CA.

Stock Forecast FAQ

In the current month, OCSL has received 0 Buy ratings 6 Hold ratings, and 0 Sell ratings. The OCSL average analyst price target in the past 3 months is $13.70.

  • Where Will Oaktree Specialty Lending Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Oaktree Specialty Lending Corp. share price will rise to $13.70 per share over the next 12 months.

  • What Do Analysts Say About Oaktree Specialty Lending Corp.?

    Analysts are divided on their view about Oaktree Specialty Lending Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oaktree Specialty Lending Corp. is a Sell and believe this share price will drop from its current level to $13.00.

  • What Is Oaktree Specialty Lending Corp.'s Price Target?

    The price target for Oaktree Specialty Lending Corp. over the next 1-year time period is forecast to be $13.70 according to 6 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is OCSL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Oaktree Specialty Lending Corp. is a Hold. 6 of 6 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of OCSL?

    You can purchase shares of Oaktree Specialty Lending Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oaktree Specialty Lending Corp. shares.

  • What Is The Oaktree Specialty Lending Corp. Share Price Today?

    Oaktree Specialty Lending Corp. was last trading at $13.58 per share. This represents the most recent stock quote for Oaktree Specialty Lending Corp.. Yesterday, Oaktree Specialty Lending Corp. closed at $13.58 per share.

  • How To Buy Oaktree Specialty Lending Corp. Stock Online?

    In order to purchase Oaktree Specialty Lending Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 18.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock